Halozyme Therapeutics (HALO) Earnings Date, Estimates & Call Transcripts $57.15 -0.48 (-0.83%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$57.16 +0.01 (+0.02%) As of 07/11/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Halozyme Therapeutics Earnings Summary Halozyme Therapeutics posted Q1 2025 earnings on May 6, 2025, reporting an EPS of $1.11, which topped analysts' consensus estimates of $0.98 by $0.13. Quarterly revenue rose 35.2% year-over-year to $264.86 million, above analyst estimates of $231.21 million. With a trailing EPS of $3.76 and a P/E Ratio of 15.20, Halozyme Therapeutics' earnings are expected to grow 31.50% next year, from $4.73 to $6.22 per share. Upcoming Q2 Earnings DateAug. 5After Market ClosesEstimatedConsensus EPS (May. 6) $0.98 Actual EPS (May. 6) $1.11 Beat By $0.13 Actual Revenue (May. 6) $264.86MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckHALO Upcoming EarningsHalozyme Therapeutics' Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Halozyme Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Halozyme Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHALO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HALO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Halozyme Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$0.88$0.93$0.91Q2 20252$1.04$1.09$1.07Q3 20252$1.31$1.41$1.36Q4 20252$1.58$1.66$1.62 FY 2025 8 $4.81 $5.09 $4.95 Q1 20261$1.02$1.02$1.02Q2 20261$1.21$1.21$1.21Q3 20261$1.46$1.46$1.46Q4 20261$1.68$1.68$1.68 FY 2026 4 $5.37 $5.37 $5.37 Q1 20271$1.19$1.19$1.19 Halozyme Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)-------5/6/2025Q1 2025$0.98$1.11+$0.13$0.93$231.21M$264.86M2/18/2025Q4 2024$1.17$1.19+$0.02$1.06$285.74M$298.01M8/6/2024Q2 2024$0.73$0.91+$0.18$0.98$204.94M$231.40M5/7/2024Q1 2024$0.64$0.71+$0.07$0.82$201.72M$195.88M2/20/2024Q4 2023$0.77$0.75 -$0.02$0.85$235.25M$230.04M11/6/2023Q3 2023$0.67$0.69+$0.02$0.77$219.47M$216.03M8/8/2023Q2 2023$0.59$0.68+$0.09$0.80$201.91M$221.04M Halozyme Therapeutics Earnings - Frequently Asked Questions When is Halozyme Therapeutics' earnings date? Halozyme Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on HALO's earnings history. What guidance has Halozyme Therapeutics issued on next quarter's earnings? Halozyme Therapeutics updated its FY 2025 earnings guidance on Tuesday, May, 6th. The company provided earnings per share (EPS) guidance of 5.300-5.700 for the period, compared to the consensus EPS estimate of 5.000. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion. Did Halozyme Therapeutics beat their earnings estimates last quarter? In the previous quarter, Halozyme Therapeutics (NASDAQ:HALO) reported $1.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.98 by $0.13. Learn more on analysts' earnings estimate vs. HALO's actual earnings. How can I listen to Halozyme Therapeutics' earnings conference call? The conference call for Halozyme Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Halozyme Therapeutics' conference call transcript? The conference call transcript for Halozyme Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Halozyme Therapeutics generate each year? Halozyme Therapeutics (NASDAQ:HALO) has a recorded annual revenue of $1.02 billion. How much profit does Halozyme Therapeutics generate each year? Halozyme Therapeutics (NASDAQ:HALO) has a recorded net income of $444.09 million. HALO has generated $3.76 earnings per share over the last four quarters. What is Halozyme Therapeutics' price-to-earnings ratio? Halozyme Therapeutics (NASDAQ:HALO) has a trailing price-to-earnings ratio of 15.20 and a forward price-to-earnings ratio of 12.08. The price/earnings-to-growth ratio is 0.38. What is Halozyme Therapeutics' EPS forecast for next year? Halozyme Therapeutics' earnings are expected to grow from $4.73 per share to $6.22 per share in the next year, which is a 31.50% increase. More Earnings Resources from MarketBeat Related Companies BIIB Earnings Date UTHR Earnings Date INCY Earnings Date NBIX Earnings Date EXEL Earnings Date BMRN Earnings Date EXAS Earnings Date RGEN Earnings Date IONS Earnings Date MDGL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:HALO) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HALO Stock Alerts